Synthego and SeQure Dx Partner to Provide Comprehensive Off-Target Analysis Services for CRISPR-Based Therapeutics Developers

REDWOOD CITY, Calif. and WALTHAM, Mass., Jan. 23, 2024 /PRNewswire/ — Synthego, a leading provider of genome engineering solutions, and SeQure Dx, a company focused on off-target analysis for preclinical and clinical gene modification customers, have announced a strategic partnership to…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks